Montelukast%252525252525252525252525252525252520levocetrizine

# Montelukast-Levocetirizine (Combination therapy is often utilized for allergic rhinitis, though usually prescribed as separate agents.) ## Overview Montelukast is a selective leukotriene receptor antagonist (LTRA). Levocetirizine is a third-generation, non-sedating H1-receptor antagonist (R-enantiomer of cetirizine). ## Primary Indications Allergic rhinitis (seasonal and perennial), chronic idiopathic urticaria (levocetirizine), and asthma (montelukast). ## Adult Dosing * **Montelukast:** 10 mg orally once daily, preferably in the evening. * **Levocetirizine:** 5 mg orally once daily, preferably in the evening (due to potential mild somnolence). ## Pediatric Dosing * **Montelukast:** * 6–14 years: 5 mg chewable tablet once daily. * 2–5 years: 4 mg oral granules or chewable tablet once daily. * 6–23 months: 4 mg oral granules once daily. * **Levocetirizine:** * 6–11 years: 2.5 mg once daily. * 12 years and older: 5 mg once daily. ## Dose Adjustments * **Renal Impairment (Levocetirizine):** Requires adjustment based on creatinine clearance (CrCl). * CrCl 30–49 mL/min: 2.5 mg once daily. * CrCl 10–29 mL/min: 2.5 mg every 48 hours. * ESRD/Dialysis: Contraindicated. * **Hepatic Impairment:** No standard adjustment for montelukast; levocetirizine adjustment is not required but caution is advised in severe cases. ## Contraindications * **Montelukast:** Hypersensitivity to the drug. * **Levocetirizine:** Hypersensitivity to levocetirizine or cetirizine; severe renal impairment (CrCl <10 mL/min); end-stage renal disease. ## Adverse Effects * **Montelukast:** Neuropsychiatric events (agitation, depression, sleep disturbances, suicidal ideation), headache, influenza, abdominal pain, elevated transaminases. * **Levocetirizine:** Somnolence (less than first-gen antihistamines but higher than other second-gen), nasopharyngitis, fatigue, dry mouth. ## Key Drug Interactions * **Montelukast:** Potentially affected by strong CYP2C8 inhibitors (e.g., gemfibrozil), which may increase montelukast exposure. * **Levocetirizine:** Depressant effects may be additive with CNS depressants or alcohol. High-dose ritonavir may increase levocetirizine levels. ## Monitoring * Monitor for neuropsychiatric changes (behavior, mood, sleep) in patients taking montelukast. * Assess for excessive sedation or urinary retention (levocetirizine). * Assess efficacy of symptom control periodically. ## Clinical Pearls * **Neuropsychiatric Warning:** The FDA issued a Boxed Warning for montelukast due to severe neuropsychiatric side effects; weigh benefits against risks, especially for mild conditions like allergic rhinitis. * **Timing:** Administer both in the evening to maximize control of nocturnal rhinitis symptoms and to mitigate potential daytime sedation from levocetirizine. * **Granules:** Montelukast oral granules may be administered directly into the mouth, dissolved in 5 mL of infant formula/breast milk, or mixed with a spoonful of cold/room temperature soft food (e.g., applesauce, rice, ice cream). Use within 15 minutes of opening. *** **Educational Disclaimer:** This information is for educational purposes only. Clinical practice guidelines and drug information can change. Always verify current prescribing information, contraindications, and patient-specific dosing in official references (e.g., Lexicomp, UpToDate) or local institutional protocols before prescribing or administering medication.